易怒性

US11096929(OVID THERAPEUTICS INC [US])
Loss of this function impairs skills such as impulse control, self-monitoring, focusing attention appropriately, and cognitive flexibility.
この機能の喪失は、衝動制御、自己監視、適切な注意力の集中および認知的柔軟性などの技能を損なう。

Many people with FXTAS experience psychiatric symptoms such as anxiety, depression, moodiness, or irritability.
多くのFXTASの患者は、精神症状、例えば不安、うつ病、不機嫌または易怒性を経験する。

WO2013155506(INTRA CELLULAR THERAPIES INC [US])
These Compounds also exhibit efficacy in reducing behavioral disturbances such as agitation and irritability as well as sleep disturbances and symptoms of depression and psychosis. 
これらの化合物はまた、行動障害、例えば激越や易怒性、ならびに睡眠障害および鬱病や精神病の症状の軽減に有効性を示す。

/////////

 This discovery gives the Compounds of the current Invention
この発見は、本発明の化合物を、

particular utility in the treatment or prophylaxis of

one or more disorders associated with dementia, particularly behavioral or mood disturbances such as agitation, irritation, aggressive/assaultive behavior, anger, physical or emotional outbursts and sleep disturbances, which conditions are often left untreated by current marketed drugs, as well as psychosis and depressive disorders in dementia patients.
現在上市されている薬物ではしばしば処置されない状態である１種以上の認知症に関連する障害、特に行動障害または気分障害、例えば激越、焦燥、好戦的／攻撃的行動、怒り、身体的または感情的爆発および睡眠障害、ならびに認知症患者における精神病および鬱病性障害

の処置または予防に、特に有用なものとする。